Selected research
Market Structure
Global Veterinary Chinese Medicine Granules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Veterinary Chinese Medicine Granules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Veterinary Chinese Medicine Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Veterinary Chinese Medicine Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Veterinary Chinese Medicine Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Veterinary Chinese Medicine Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Veterinary Chinese Medicine Granules include China Animal Husbandry Industry, Zhongmuda-Biology, Yinghe (Jiaozuo) Traditional Chinese Medicine Bioengineering, Anhui Wanshi Biopharmaceutical, Runda Biotechnology, Qingdao Zhongren Animal Pharmaceutical, Harbin Qianhe Animal Drug Manufacturing, Henan Mu Jin Biological Technology and Limin Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Veterinary Chinese Medicine Granules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Veterinary Chinese Medicine Granules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Veterinary Chinese Medicine Granules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Chinese Medicine Granules market size, projected growth trends, production technologies, key applications, and end-use industries.
Veterinary Chinese Medicine Granules Segment by Company
China Animal Husbandry Industry
Zhongmuda-Biology
Yinghe (Jiaozuo) Traditional Chinese Medicine Bioengineering
Anhui Wanshi Biopharmaceutical
Runda Biotechnology
Qingdao Zhongren Animal Pharmaceutical
Harbin Qianhe Animal Drug Manufacturing
Henan Mu Jin Biological Technology
Limin Group
Jizhong Pharmaceutical
Wuhan Huisheng Biotechnology
Depond
Bolai Yaoye
Tsumura
Puyer International Group
Veterinary Chinese Medicine Granules Segment by Type
Veterinary Banqing Granules
Veterinary Maxingshigan Drug
Others
Veterinary Chinese Medicine Granules Segment by Application
Pigs
Sheep
Cattle
Chickens
Others
Veterinary Chinese Medicine Granules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Chinese Medicine Granules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Chinese Medicine Granules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Chinese Medicine Granules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Veterinary Chinese Medicine Granules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Chinese Medicine Granules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Veterinary Chinese Medicine Granules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Veterinary Chinese Medicine Granules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Veterinary Banqing Granules
- Veterinary Maxingshigan Drug
- Others
Applications
- Pigs
- Sheep
- Cattle
- Chickens
- Others
Companies covered
- China Animal Husbandry Industry
- Zhongmuda-Biology
- Yinghe (Jiaozuo) Traditional Chinese Medicine Bioengineering
- Anhui Wanshi Biopharmaceutical
- Runda Biotechnology
- Qingdao Zhongren Animal Pharmaceutical
- Harbin Qianhe Animal Drug Manufacturing
- Henan Mu Jin Biological Technology
- Limin Group
- Jizhong Pharmaceutical
- Wuhan Huisheng Biotechnology
- Depond
- Bolai Yaoye
- Tsumura
- Puyer International Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Veterinary Chinese Medicine Granules Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Veterinary Chinese Medicine Granules Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Veterinary Chinese Medicine Granules Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Veterinary Chinese Medicine Granules Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Veterinary Chinese Medicine Granules Market Dynamics
- 2.1 Veterinary Chinese Medicine Granules Industry Trends
- 2.2 Veterinary Chinese Medicine Granules Industry Drivers
- 2.3 Veterinary Chinese Medicine Granules Industry Opportunities and Challenges
- 2.4 Veterinary Chinese Medicine Granules Industry Restraints
3 Veterinary Chinese Medicine Granules Market by Manufacturers
- 3.1 Global Veterinary Chinese Medicine Granules Revenue by Manufacturers (2021-2026)
- 3.2 Global Veterinary Chinese Medicine Granules Sales by Manufacturers (2021-2026)
- 3.3 Global Veterinary Chinese Medicine Granules Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Veterinary Chinese Medicine Granules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Veterinary Chinese Medicine Granules Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Veterinary Chinese Medicine Granules Manufacturers, Product Type & Application
- 3.7 Global Veterinary Chinese Medicine Granules Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Veterinary Chinese Medicine Granules Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Veterinary Chinese Medicine Granules Players Market Share by Revenue in 2025
- 3.8.3 2025 Veterinary Chinese Medicine Granules Tier 1, Tier 2, and Tier 3
4 Veterinary Chinese Medicine Granules Market by Type
- 4.1 Veterinary Chinese Medicine Granules Type Introduction
- 4.1.1 Veterinary Banqing Granules
- 4.1.2 Veterinary Maxingshigan Drug
- 4.1.3 Others
- 4.2 Global Veterinary Chinese Medicine Granules Sales by Type
- 4.2.1 Global Veterinary Chinese Medicine Granules Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Veterinary Chinese Medicine Granules Sales by Type (2021-2032)
- 4.2.3 Global Veterinary Chinese Medicine Granules Sales Market Share by Type (2021-2032)
- 4.3 Global Veterinary Chinese Medicine Granules Revenue by Type
- 4.3.1 Global Veterinary Chinese Medicine Granules Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Veterinary Chinese Medicine Granules Revenue by Type (2021-2032)
- 4.3.3 Global Veterinary Chinese Medicine Granules Revenue Market Share by Type (2021-2032)
5 Veterinary Chinese Medicine Granules Market by Application
- 5.1 Veterinary Chinese Medicine Granules Application Introduction
- 5.1.1 Pigs
- 5.1.2 Sheep
- 5.1.3 Cattle
- 5.1.4 Chickens
- 5.1.5 Others
- 5.2 Global Veterinary Chinese Medicine Granules Sales by Application
- 5.2.1 Global Veterinary Chinese Medicine Granules Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Veterinary Chinese Medicine Granules Sales by Application (2021-2032)
- 5.2.3 Global Veterinary Chinese Medicine Granules Sales Market Share by Application (2021-2032)
- 5.3 Global Veterinary Chinese Medicine Granules Revenue by Application
- 5.3.1 Global Veterinary Chinese Medicine Granules Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Veterinary Chinese Medicine Granules Revenue by Application (2021-2032)
- 5.3.3 Global Veterinary Chinese Medicine Granules Revenue Market Share by Application (2021-2032)
6 Global Veterinary Chinese Medicine Granules Sales by Region
- 6.1 Global Veterinary Chinese Medicine Granules Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Veterinary Chinese Medicine Granules Sales by Region (2021-2032)
- 6.2.1 Global Veterinary Chinese Medicine Granules Sales by Region (2021-2026)
- 6.2.2 Global Veterinary Chinese Medicine Granules Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Veterinary Chinese Medicine Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Veterinary Chinese Medicine Granules Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Veterinary Chinese Medicine Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Veterinary Chinese Medicine Granules Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Veterinary Chinese Medicine Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Veterinary Chinese Medicine Granules Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Veterinary Chinese Medicine Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Veterinary Chinese Medicine Granules Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Veterinary Chinese Medicine Granules Revenue by Region
- 7.1 Global Veterinary Chinese Medicine Granules Revenue by Region
- 7.1.1 Global Veterinary Chinese Medicine Granules Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Veterinary Chinese Medicine Granules Revenue by Region (2021-2026)
- 7.1.3 Global Veterinary Chinese Medicine Granules Revenue by Region (2027-2032)
- 7.1.4 Global Veterinary Chinese Medicine Granules Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Veterinary Chinese Medicine Granules Revenue (2021-2032)
- 7.2.2 North America Veterinary Chinese Medicine Granules Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Veterinary Chinese Medicine Granules Revenue (2021-2032)
- 7.3.2 Europe Veterinary Chinese Medicine Granules Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Veterinary Chinese Medicine Granules Revenue (2021-2032)
- 7.4.2 Asia-Pacific Veterinary Chinese Medicine Granules Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Veterinary Chinese Medicine Granules Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Veterinary Chinese Medicine Granules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 China Animal Husbandry Industry
- 8.1.1 China Animal Husbandry Industry Company Information
- 8.1.2 China Animal Husbandry Industry Business Overview
- 8.1.3 China Animal Husbandry Industry Veterinary Chinese Medicine Granules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 China Animal Husbandry Industry Veterinary Chinese Medicine Granules Product Portfolio
- 8.1.5 China Animal Husbandry Industry Recent Developments
- 8.2 Zhongmuda-Biology
- 8.2.1 Zhongmuda-Biology Company Information
- 8.2.2 Zhongmuda-Biology Business Overview
- 8.2.3 Zhongmuda-Biology Veterinary Chinese Medicine Granules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Zhongmuda-Biology Veterinary Chinese Medicine Granules Product Portfolio
- 8.2.5 Zhongmuda-Biology Recent Developments
- 8.3 Yinghe (Jiaozuo) Traditional Chinese Medicine Bioengineering
- 8.3.1 Yinghe (Jiaozuo) Traditional Chinese Medicine Bioengineering Company Information
- 8.3.2 Yinghe (Jiaozuo) Traditional Chinese Medicine Bioengineering Business Overview
- 8.3.3 Yinghe (Jiaozuo) Traditional Chinese Medicine Bioengineering Veterinary Chinese Medicine Granules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Yinghe (Jiaozuo) Traditional Chinese Medicine Bioengineering Veterinary Chinese Medicine Granules Product Portfolio
- 8.3.5 Yinghe (Jiaozuo) Traditional Chinese Medicine Bioengineering Recent Developments
- 8.4 Anhui Wanshi Biopharmaceutical
- 8.4.1 Anhui Wanshi Biopharmaceutical Company Information
- 8.4.2 Anhui Wanshi Biopharmaceutical Business Overview
- 8.4.3 Anhui Wanshi Biopharmaceutical Veterinary Chinese Medicine Granules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Anhui Wanshi Biopharmaceutical Veterinary Chinese Medicine Granules Product Portfolio
- 8.4.5 Anhui Wanshi Biopharmaceutical Recent Developments
- 8.5 Runda Biotechnology
- 8.5.1 Runda Biotechnology Company Information
- 8.5.2 Runda Biotechnology Business Overview
- 8.5.3 Runda Biotechnology Veterinary Chinese Medicine Granules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Runda Biotechnology Veterinary Chinese Medicine Granules Product Portfolio
- 8.5.5 Runda Biotechnology Recent Developments
- 8.6 Qingdao Zhongren Animal Pharmaceutical
- 8.6.1 Qingdao Zhongren Animal Pharmaceutical Company Information
- 8.6.2 Qingdao Zhongren Animal Pharmaceutical Business Overview
- 8.6.3 Qingdao Zhongren Animal Pharmaceutical Veterinary Chinese Medicine Granules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Qingdao Zhongren Animal Pharmaceutical Veterinary Chinese Medicine Granules Product Portfolio
- 8.6.5 Qingdao Zhongren Animal Pharmaceutical Recent Developments
- 8.7 Harbin Qianhe Animal Drug Manufacturing
- 8.7.1 Harbin Qianhe Animal Drug Manufacturing Company Information
- 8.7.2 Harbin Qianhe Animal Drug Manufacturing Business Overview
- 8.7.3 Harbin Qianhe Animal Drug Manufacturing Veterinary Chinese Medicine Granules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Harbin Qianhe Animal Drug Manufacturing Veterinary Chinese Medicine Granules Product Portfolio
- 8.7.5 Harbin Qianhe Animal Drug Manufacturing Recent Developments
- 8.8 Henan Mu Jin Biological Technology
- 8.8.1 Henan Mu Jin Biological Technology Company Information
- 8.8.2 Henan Mu Jin Biological Technology Business Overview
- 8.8.3 Henan Mu Jin Biological Technology Veterinary Chinese Medicine Granules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Henan Mu Jin Biological Technology Veterinary Chinese Medicine Granules Product Portfolio
- 8.8.5 Henan Mu Jin Biological Technology Recent Developments
- 8.9 Limin Group
- 8.9.1 Limin Group Company Information
- 8.9.2 Limin Group Business Overview
- 8.9.3 Limin Group Veterinary Chinese Medicine Granules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Limin Group Veterinary Chinese Medicine Granules Product Portfolio
- 8.9.5 Limin Group Recent Developments
- 8.10 Jizhong Pharmaceutical
- 8.10.1 Jizhong Pharmaceutical Company Information
- 8.10.2 Jizhong Pharmaceutical Business Overview
- 8.10.3 Jizhong Pharmaceutical Veterinary Chinese Medicine Granules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Jizhong Pharmaceutical Veterinary Chinese Medicine Granules Product Portfolio
- 8.10.5 Jizhong Pharmaceutical Recent Developments
- 8.11 Wuhan Huisheng Biotechnology
- 8.11.1 Wuhan Huisheng Biotechnology Company Information
- 8.11.2 Wuhan Huisheng Biotechnology Business Overview
- 8.11.3 Wuhan Huisheng Biotechnology Veterinary Chinese Medicine Granules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Wuhan Huisheng Biotechnology Veterinary Chinese Medicine Granules Product Portfolio
- 8.11.5 Wuhan Huisheng Biotechnology Recent Developments
- 8.12 Depond
- 8.12.1 Depond Company Information
- 8.12.2 Depond Business Overview
- 8.12.3 Depond Veterinary Chinese Medicine Granules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Depond Veterinary Chinese Medicine Granules Product Portfolio
- 8.12.5 Depond Recent Developments
- 8.13 Bolai Yaoye
- 8.13.1 Bolai Yaoye Company Information
- 8.13.2 Bolai Yaoye Business Overview
- 8.13.3 Bolai Yaoye Veterinary Chinese Medicine Granules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Bolai Yaoye Veterinary Chinese Medicine Granules Product Portfolio
- 8.13.5 Bolai Yaoye Recent Developments
- 8.14 Tsumura
- 8.14.1 Tsumura Company Information
- 8.14.2 Tsumura Business Overview
- 8.14.3 Tsumura Veterinary Chinese Medicine Granules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Tsumura Veterinary Chinese Medicine Granules Product Portfolio
- 8.14.5 Tsumura Recent Developments
- 8.15 Puyer International Group
- 8.15.1 Puyer International Group Company Information
- 8.15.2 Puyer International Group Business Overview
- 8.15.3 Puyer International Group Veterinary Chinese Medicine Granules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Puyer International Group Veterinary Chinese Medicine Granules Product Portfolio
- 8.15.5 Puyer International Group Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Veterinary Chinese Medicine Granules Value Chain Analysis
- 9.1.1 Veterinary Chinese Medicine Granules Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Veterinary Chinese Medicine Granules Production Mode & Process
- 9.2 Veterinary Chinese Medicine Granules Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Veterinary Chinese Medicine Granules Distributors
- 9.2.3 Veterinary Chinese Medicine Granules Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst